BioSpace News Archive

Business

Alnylam Pharmaceuticals and Cubist Pharmaceuticals, Inc. Form Strategic Collaboration to Develop and Commercialize RNAi Therapeutics Targeting Respiratory Syncytial Virus (RSV) Infection; Alnylam to Get $20 Million Upfront

January 9, 2009
·
11 min read
Drug Development

US FDA Backs Merck & Co., Inc. (JOBS), Schering-Plough Corporation’s (JOBS) Vytorin

January 9, 2009
·
1 min read
Irish Domiciled Funds Exceed €1 Trillion

January 9, 2009
·
1 min read
FDA

FDA Advisory Committee Unanimously Recommends OVATION Pharmaceuticals (Acquired by Lundbeck in March 2009)'s Sabril(R) (vigabatrin) for the Treatment of Two Catastrophic Epilepsies

January 9, 2009
·
5 min read
Business

XDx, Inc. and Bristol-Myers Squibb Enter into Pharmacogenomics Collaboration

January 9, 2009
·
3 min read
Antipsychotics For Alzheimer’s Up Death Risk, King’s College London Study

January 9, 2009
·
1 min read
Drug Development

Protein Might One Day Prevent Blindness, Howard Hughes Medical Institute Study

January 9, 2009
·
1 min read
Drug Development

New Drug May Work Better Against Chemo Side Effects, Juntendo University Hospital Study

January 9, 2009
·
1 min read
Drug Development

Body Repair ‘Could Be Ramped Up’, Imperial College London Study

January 9, 2009
·
1 min read
BioMidwest

Case Western Reserve University Professor Explores Schistosomiasis Elimination In NEJM Perspective

January 9, 2009
·
1 min read